OncoMatch/Clinical Trials/NCT03823534
Post-Op Pain Control for Prophylactic Intramedullary Nailing.
Is NCT03823534 recruiting? Yes, currently enrolling (Jun 2026). This Phase 3 trial studies multiple treatments for bone metastases.
Treatment: Ketorolac · Normal saline · Acetaminophen · Oxycodone Acetaminophen · Morphine · Hydrocodone/Acetaminophen · Oxycodone — Nationally, the opioid crisis has become a major epidemic with increasing mortality rates each year. Orthopedic surgeons routinely prescribe narcotics instead of NSAIDs for post-op pain control because of risk of delayed healing and nonunion due to NSAID use. Orthopedic oncology, however, has a unique subset of patients that undergo prophylactic placement of intramedullary femoral nails. Because no fracture is present, these patients do not rely on inflammatory healing factors, allowing for post-op NSAID use. This study sets out to determine the effect of post-op toradol use in addition to opioids compared to solely opioids in patients undergoing prophylactic nailing of the femur.
Check if I qualifyExtracted eligibility criteria
Treatments studied
Other
Cancer type
Non-Hodgkin Lymphoma
Hodgkin Lymphoma
Multiple Myeloma
Lab requirements
Kidney function
No advanced renal impairment (eGFR<30mL/min)
History of advanced renal impairment (eGFR<30mL/min) [excluded]
Structured fields extracted by AI. May contain errors — verify against the official protocol.
US trial sites
- Saint Louis University · St Louis, Missouri
Showing up to 5 US sites.
See all sites on ClinicalTrials.gov →Frequently asked questions
Is NCT03823534 currently recruiting?
Yes, this trial is currently recruiting patients.
Could you qualify for this trial?
Enter your biomarker results to see how this trial's eligibility criteria match your specific cancer profile.
Check if I qualifyRelated pages